Russians have always tried to push ahead of the curve. They were in the race to space, and very close to landing on the moon before any other country. Russia has also continually showed their power throughout history as a military and economic superpower

Russian nootropics have also been an area of incredible advancement. The Russian government has long been interested in developing nootropic drugs to increase mental stamina and strength.

Millions of dollars of research have been funded by Russia to the Molecular Genetics of the Russian academy of sciences. Russia has interest as a society to create drugs to improve people’s cognition and lives. Other countries do not have the same attitudes as drugs are about pure profits rather than creating compounds to improve the everyday person


Noopept, also known as GSV-111 was first developed in Russia. It was one of the first compounds to be prescribed as an actual nootropic strictly meant not to treat a condition, but to increase cognitive function in the healthy as well. Long ago it was only available through the manufacturer but now many copycats have identified the formula and created it in other countries.

Noopept is perhaps one of the most popular cholinergic nootropics worldwide behind piracetam and aniracetam. In the recent years it has become very popular in North America, the UK and Australia. Over a decade ago, noopept was only available is Russia and the surrounding countries however the increased demand has spread it and created a demand that has pushed the price down. It is still raising in the ranks to become one of the most popular nootropics.


Phenylpiracetam is another nootropic created in Russia that has gained a lot of attention. It is not yet as popular as noopept but has gained increasing popularity in the west. It has even been banned from the Olympics by the World Anti-Doping agency.

Phenylpiracetam is known as Phenotropil in Russia but like with noopept, the formula has been copied and sent to many other countries. One disadvantage with phenylpiracetam is the cost. Unlike noopept, it is much more expensive to produce and this has been a hindrance is growing it as a worldwide popularity.


Semax is another exciting and new nootropic that was created in Russia. It has been studied extensively by Russian scientists and recognized by the local government as a powerful cognitive enhancer. It has not yet become extremely popular but worldwide knowledge is beginning to spread.

There are several hindrances with Semax becoming a popular and widespread nootropic. First, its formula is very expensive and difficult to create by copycats. Also, it requires special temperature requirements (must remain below 50 degrees F on transport or it loses potency). The only manufacterer of Semax is in Russia and this has lent Semax to remain very expensive and still unpopular in many countries


Cerebrolysin is another newer nootropic drug synthesized from pig brain proteins. It was created in Russia and has been evaluated as an Alzheimer’s disease treatment in Russia and surrounding countries. So far, Russian research has shown positive results. This nootropic may still have its time to shine as further research and reports become available.

Like with Semax, there are several things that make cerebrolysin unpopular as a nootropic in North America and other countries. Since it is a peptide, it has to be injected intramuscularly which obviously creates a barrier for safe and daily use as a general nootropic. Like with Semax, the availability of cerebrolysin is limited as the manufacturer is the only place to create it. Regardless, this peptide drug has gained a lot of interest.


Selank is yet another Russian nootropic peptide. Like cerebrolysin, it has to be injected which makes it less attractive as a daily nootropic. Some chemical research peptide companies have recreated the selank structure however these are not intended for human consumption and should be avoided.

Selanks’ method of action is entirely unique of most other nootropics. It is thought to modulate the concentration of monoamine neurotransmitters. This may have incredible benefits for cognition. Another recognized benefit is its alleged effects on brain-derived neurotropic factor (BDNF). The effects of Selank are still being studied and it may open the door to the next generation of nootropic drugs.